Credit Suisse’s Insys Therapeutics, Inc. INSY Stock Holding History

Credit Suisse’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-14,100	Closed	-$401K	–	4440
2015 Q3	$401K	Buy	+14,100	New	+$519K	﹤0.01%	3555
2014 Q4	–	Sell	-65,800	Closed	-$1.28M	–	4802
2014 Q3	$1.28M	Buy	+65,800	New	+$1.03M	﹤0.01%	2848

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Credit Suisse's INSY Position: Q2 2019 in Review

Credit Suisse sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 18,869 shares — an estimated $86K sold.

Credit Suisse first reported a position in INSY in Q3 2013 and held it in 23 quarters. The position peaked at $4.46M in Q2 2015. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Credit Suisse reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Credit Suisse sold 18,869 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $86K.
Credit Suisse first reported a position in Insys Therapeutics, Inc. in Q3 2013 and held it in 23 quarters.
Credit Suisse's Insys Therapeutics, Inc. position peaked at $4.46M in Q2 2015.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Credit Suisse's 13F filing for Q2 2019, filed 14 Aug 2019.